The complexity of cancer makes personalization vital to cancer treatment. RGCC Oncotrail is a groundbreaking diagnostic tool that is set to revolutionize cancer monitoring and management. The tests are tailored to address specific cancer types, including breast, prostate, colon, melanoma, lung, sarcoma, gastrointestinal, and more.
RGCC Oncotrail is a follow-up test that is used to track Circulating Tumor Cells (CTCs). By analyzing CTCs, and the activity of the stemness markers and markers specific to your specific type of cancer, the OncoTrail results add crucial information about your cancer prognosis as it is designed specifically to provide the information specific to your specific type of cancer.
Utilizing cutting-edge technology, this non-invasive approach allows for precise tracking of cancer progression.
CTC Count: Helps to determine the complexity of the disease, studies show a direct correlation between the CTC count and overall tumor burden. The CTC count helps clinicians assess the treatment responses.
Phenotype markers: Phenotype markers serve as important tools for cancer research, facilitating the discovery of new treatment targets and the development of innovative diagnostic and therapeutic approaches. Phenotype markers play a crucial role in guiding treatment decisions.
Stemness markers: Like the Oncotrace test, Oncotrail also provides crucial information on the important cancer stem cells (CSCs) responsible for tumor initiation, progression, metastasis, and treatment resistance.
Oncotrail test is a comprehensive tool that reveals the presence and concentration of circulating tumor cells (CTCs). The test helps in developing specialized treatment plans for specific forms of cancer, such as Breast cancer, Colon, GI, Melanoma, Lung, Sarcoma, and Prostate.
The first step towards personalized cancer care is scheduling an appointment with us.
Upon booking the appointment, you get a consultation with our RGCC experts to assess your cancer status.
We guide you through the process of selecting the most effective tests for your specific cancer.
We deliver precise results that guide treatment decisions and enhance outcomes.
“RGCC’s Oncotrail test is essential for monitoring cancer progression and treatment response. Its accuracy allows for timely adjustments to therapy, improving patient outcomes and quality of life. A critical tool in personalized cancer care.”
Our RGCC accredited experts are here to help you with their expertise and guide you in your fight against cancer.
OncoTrail test helps in developing an individualized treatment plan tailored for specific types of cancers like Breast cancer, Colon cancer, GI cancer, Melanoma cancer, Lung cancer, Sarcoma cancer, and Prostate cancer.
We suggest undergoing the RGCC ONCOTRAIL test every three months during active cancer treatment to evaluate the efficacy of the ongoing treatment plan.
Every 3 months for 1 year after completing the treatment/surgery to monitor for early relapse/recurrence.
Our cutting edge diagnostics and personalised tests makes a meaningful difference in the fight against cancer.
Absolutely, tests can be performed while undergoing treatment to assess the effectiveness of the treatment against cancer.
Your blood sample undergoes processing in cutting-edge laboratories by scientists and technicians to deliver insights into your cancer cells.
Yes, all RGCC tests utilize blood samples. However, certain cancers, like glioblastoma and brain tumors, may require additional samples such as CSF or tissue. Otherwise, a peripheral blood sample alone is enough.
Yes, tests like aCGH can pinpoint the origin of an unknown primary tumor by analyzing genetic abnormalities present in tumor cells.
RGCC Metastat is an effective test for identifying secondary tumors development and its potential location. It helps detect secondary tumors through analyzing Circulating Tumor Cells (CTCs) in the bloodstream. The test provides valuable insights into disease progression and metastasis.
Tests personalize treatment regimens by providing crucial information on drugs and therapies tailored to effectively target cancer cells.
Circulating Tumor Cells (CTCs) are cancer cells that have detached from the primary tumor and circulate in the bloodstream. Cancer Stem Cells (CSCs) are a subpopulation of CTCs and both serve as biomarkers for cancer.
Tests like ChemoSNiP and CAMBISeq provide information on the body’s response to the drugs and sensitivity to immunotherapy.
Looking to stay ahead in your cancer treatment journey? With RGCC Oncotrail, you can gain vital insights into the effectiveness of your ongoing treatments. Choose RGCC Oncotrail and empower yourself with the knowledge to navigate your cancer journey confidently.
Offering personalized tests from RGCC, our mission is to improve treatment outcomes, enhance survival rates, and elevate overall quality of life for those affected by cancer.
Copyright 2024 © All Right Reserved.
Designed by Bee High Media